Thermo Profit Margin vs Accounts Payable Analysis

TMO Stock

USD 541.52 5.73 1.05%

Thermo Fisher financial indicator trend analysis is much more than just breaking down Thermo Fisher Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Thermo Fisher Scientific is a good investment. Please check the relationship between Thermo Fisher Net Profit Margin and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Net Profit Margin vs Accounts Payable

Profit Margin vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Thermo Fisher Scientific Profit Margin account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Thermo Fisher's Profit Margin and Accounts Payable is 0.81. Overlapping area represents the amount of variation of Profit Margin that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Thermo Fisher Scientific, assuming nothing else is changed. The correlation between historical values of Thermo Fisher's Profit Margin and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Profit Margin of Thermo Fisher Scientific are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Profit Margin i.e., Thermo Fisher's Profit Margin and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.81

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Net Profit Margin

The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.

Accounts Payable

An accounting item on the balance sheet that represents Thermo Fisher obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Thermo Fisher Scientific are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Thermo Fisher's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Thermo Fisher Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At this time, Thermo Fisher's Selling General Administrative is very stable compared to the past year. As of the 18th of April 2024, Tax Provision is likely to grow to about 469.3 M, while Discontinued Operations is likely to drop (3.6 M).

	2021	2022	2023	2024 (projected)
Total Revenue	39.2B	44.9B	42.9B	45.0B
Depreciation And Amortization	2.1B	3.7B	3.4B	3.6B

Total Revenue Depreciation And Amortization

Thermo Fisher fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Current Deferred Revenue	Good Will
Total Assets		0.99	0.83	0.97	0.99	0.98	0.95	0.97	0.75	0.99	0.45	0.75	0.98	0.38	0.98	0.99	0.87	-0.36	1.0	0.95	0.85	0.88	0.98	0.94	0.96	0.99
Short Long Term Debt Total	0.99		0.85	0.97	0.98	0.97	0.96	0.96	0.72	0.99	0.44	0.72	0.97	0.34	0.98	0.98	0.87	-0.39	1.0	0.93	0.86	0.88	0.96	0.94	0.96	0.99
Other Current Liab	0.83	0.85		0.79	0.8	0.73	0.87	0.71	0.5	0.85	0.3	0.5	0.76	0.53	0.79	0.8	0.63	0.0	0.84	0.7	0.75	0.93	0.75	0.66	0.69	0.83
Total Current Liabilities	0.97	0.97	0.79		0.96	0.99	0.9	0.97	0.8	0.95	0.31	0.8	0.98	0.28	0.94	0.98	0.82	-0.48	0.98	0.96	0.93	0.8	0.98	0.95	0.97	0.96
Total Stockholder Equity	0.99	0.98	0.8	0.96		0.96	0.91	0.98	0.77	0.98	0.46	0.77	0.97	0.41	0.97	0.99	0.89	-0.34	0.98	0.95	0.84	0.86	0.97	0.93	0.94	0.99
Property Plant And Equipment Net	0.98	0.97	0.73	0.99	0.96		0.9	0.97	0.78	0.95	0.37	0.78	1.0	0.26	0.94	0.99	0.82	-0.51	0.98	0.96	0.86	0.78	1.0	0.96	0.98	0.96
Net Debt	0.95	0.96	0.87	0.9	0.91	0.9		0.89	0.51	0.97	0.44	0.51	0.91	0.37	0.94	0.92	0.82	-0.29	0.96	0.8	0.77	0.93	0.9	0.88	0.9	0.97
Retained Earnings	0.97	0.96	0.71	0.97	0.98	0.97	0.89		0.8	0.96	0.45	0.8	0.97	0.22	0.97	0.97	0.92	-0.53	0.96	0.97	0.85	0.76	0.97	0.98	0.98	0.97
Cash	0.75	0.72	0.5	0.8	0.77	0.78	0.51	0.8		0.67	0.27	1.0	0.78	0.14	0.71	0.77	0.66	-0.49	0.72	0.91	0.76	0.42	0.78	0.75	0.75	0.69
Non Current Assets Total	0.99	0.99	0.85	0.95	0.98	0.95	0.97	0.96	0.67		0.47	0.67	0.96	0.41	0.98	0.97	0.88	-0.31	0.99	0.9	0.83	0.91	0.95	0.93	0.94	1.0
Non Currrent Assets Other	0.45	0.44	0.3	0.31	0.46	0.37	0.44	0.45	0.27	0.47		0.27	0.39	0.08	0.55	0.39	0.59	-0.07	0.44	0.39	0.05	0.39	0.35	0.42	0.44	0.47
Cash And Short Term Investments	0.75	0.72	0.5	0.8	0.77	0.78	0.51	0.8	1.0	0.67	0.27		0.78	0.14	0.71	0.77	0.66	-0.49	0.72	0.91	0.76	0.42	0.78	0.75	0.75	0.69
Net Receivables	0.98	0.97	0.76	0.98	0.97	1.0	0.91	0.97	0.78	0.96	0.39	0.78		0.31	0.94	0.99	0.81	-0.46	0.98	0.96	0.85	0.81	1.0	0.94	0.97	0.97
Common Stock Shares Outstanding	0.38	0.34	0.53	0.28	0.41	0.26	0.37	0.22	0.14	0.41	0.08	0.14	0.31		0.28	0.37	0.16	0.64	0.35	0.26	0.25	0.63	0.3	0.11	0.14	0.36
Non Current Liabilities Total	0.98	0.98	0.79	0.94	0.97	0.94	0.94	0.97	0.71	0.98	0.55	0.71	0.94	0.28		0.95	0.94	-0.42	0.97	0.92	0.81	0.83	0.94	0.96	0.96	0.99
Inventory	0.99	0.98	0.8	0.98	0.99	0.99	0.92	0.97	0.77	0.97	0.39	0.77	0.99	0.37	0.95		0.83	-0.39	0.99	0.96	0.85	0.85	0.99	0.93	0.95	0.98
Other Current Assets	0.87	0.87	0.63	0.82	0.89	0.82	0.82	0.92	0.66	0.88	0.59	0.66	0.81	0.16	0.94	0.83		-0.45	0.85	0.83	0.71	0.68	0.81	0.91	0.87	0.89
Other Stockholder Equity	-0.36	-0.39	0.0	-0.48	-0.34	-0.51	-0.29	-0.53	-0.49	-0.31	-0.07	-0.49	-0.46	0.64	-0.42	-0.39	-0.45		-0.38	-0.49	-0.44	0.05	-0.47	-0.62	-0.59	-0.36
Total Liab	1.0	1.0	0.84	0.98	0.98	0.98	0.96	0.96	0.72	0.99	0.44	0.72	0.98	0.35	0.97	0.99	0.85	-0.38		0.93	0.86	0.88	0.97	0.94	0.96	0.99
Total Current Assets	0.95	0.93	0.7	0.96	0.95	0.96	0.8	0.97	0.91	0.9	0.39	0.91	0.96	0.26	0.92	0.96	0.83	-0.49	0.93		0.86	0.7	0.96	0.93	0.94	0.92
Short Term Debt	0.85	0.86	0.75	0.93	0.84	0.86	0.77	0.85	0.76	0.83	0.05	0.76	0.85	0.25	0.81	0.85	0.71	-0.44	0.86	0.86		0.69	0.85	0.85	0.84	0.83
Intangible Assets	0.88	0.88	0.93	0.8	0.86	0.78	0.93	0.76	0.42	0.91	0.39	0.42	0.81	0.63	0.83	0.85	0.68	0.05	0.88	0.7	0.69		0.8	0.7	0.73	0.89
Accounts Payable	0.98	0.96	0.75	0.98	0.97	1.0	0.9	0.97	0.78	0.95	0.35	0.78	1.0	0.3	0.94	0.99	0.81	-0.47	0.97	0.96	0.85	0.8		0.94	0.96	0.96
Property Plant And Equipment Gross	0.94	0.94	0.66	0.95	0.93	0.96	0.88	0.98	0.75	0.93	0.42	0.75	0.94	0.11	0.96	0.93	0.91	-0.62	0.94	0.93	0.85	0.7	0.94		0.99	0.94
Current Deferred Revenue	0.96	0.96	0.69	0.97	0.94	0.98	0.9	0.98	0.75	0.94	0.44	0.75	0.97	0.14	0.96	0.95	0.87	-0.59	0.96	0.94	0.84	0.73	0.96	0.99		0.96
Good Will	0.99	0.99	0.83	0.96	0.99	0.96	0.97	0.97	0.69	1.0	0.47	0.69	0.97	0.36	0.99	0.98	0.89	-0.36	0.99	0.92	0.83	0.89	0.96	0.94	0.96

Click cells to compare fundamentals

Thermo Fisher Account Relationship Matchups

Thermo Fisher fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	58.4B	69.1B	95.1B	97.2B	98.7B	103.7B
Short Long Term Debt Total	17.8B	21.7B	34.9B	34.5B	34.9B	36.7B
Other Current Liab	2.7B	4.2B	5.4B	5.4B	4.8B	5.1B
Total Current Liabilities	6.2B	10.3B	13.4B	17.0B	14.0B	14.7B
Total Stockholder Equity	29.7B	34.5B	40.8B	44.0B	46.7B	49.1B
Property Plant And Equipment Net	5.4B	6.7B	9.9B	10.9B	9.4B	9.9B
Net Debt	15.4B	11.4B	30.4B	26.0B	26.8B	28.2B
Retained Earnings	22.1B	28.1B	35.4B	41.9B	47.4B	49.7B
Cash	2.4B	10.3B	4.5B	8.5B	8.1B	8.5B
Non Current Assets Total	45.2B	45.5B	72.0B	69.7B	74.1B	77.8B
Non Currrent Assets Other	1.9B	2.5B	4.4B	(2.8B)	4.0B	4.2B
Cash And Short Term Investments	2.4B	10.3B	4.5B	8.5B	8.1B	8.5B
Net Receivables	5.0B	6.5B	8.9B	9.4B	8.2B	8.6B
Common Stock Shares Outstanding	403M	399M	397M	394M	388M	272.7M
Liabilities And Stockholders Equity	58.4B	69.1B	95.1B	97.2B	98.7B	103.7B
Non Current Liabilities Total	17.1B	19.1B	32.1B	28.8B	37.9B	39.8B
Inventory	3.4B	4.0B	5.1B	5.6B	5.1B	5.3B
Other Current Assets	1.2B	1.1B	1.6B	1.6B	3.2B	3.4B
Other Stockholder Equity	7.1B	6.0B	4.9B	1.6B	2.1B	2.0B
Total Liab	28.7B	34.5B	54.1B	53.0B	51.9B	54.5B
Total Current Assets	11.9B	22.0B	20.1B	25.2B	24.6B	25.8B
Short Term Debt	676M	2.6B	2.5B	5.6B	3.6B	3.8B
Intangible Assets	14.0B	12.7B	20.1B	17.5B	16.7B	17.5B
Accounts Payable	1.9B	2.2B	2.9B	3.4B	2.9B	3.0B
Property Plant And Equipment Gross	4.7B	5.9B	12.6B	14.3B	15.5B	16.3B
Accumulated Other Comprehensive Income	(2.7B)	(2.8B)	(2.3B)	(3.1B)	(3.2B)	(3.1B)
Current Deferred Revenue	916M	1.3B	2.7B	2.6B	2.7B	2.8B
Good Will	25.7B	26.0B	41.9B	41.2B	44.0B	46.2B
Common Stock Total Equity	434M	437M	439M	441M	507.2M	352.8M
Short Term Investments	26M	31M	37M	28M	1.8M	1.7M
Common Stock	434M	437M	439M	441M	442M	357.4M
Other Liab	4.8B	5.1B	8.1B	5.7B	6.5B	6.9B
Other Assets	1.2B	1.6B	3.0B	2.2B	2.6B	2.7B
Long Term Debt	17.1B	19.1B	32.3B	28.9B	31.3B	32.9B
Treasury Stock	(3.7B)	(5.2B)	(6.8B)	(8.9B)	(8.0B)	(7.6B)
Property Plant Equipment	4.7B	5.9B	8.3B	9.3B	10.7B	11.2B
Net Tangible Assets	(10.1B)	(4.2B)	(21.2B)	(14.5B)	(13.1B)	(13.7B)
Retained Earnings Total Equity	22.1B	28.1B	35.4B	41.9B	48.2B	50.6B

Currently Active Assets on Macroaxis

BAC	Bank of America
DD	Dupont De Nemours
F	Ford Motor
WD	Walker Dunlop
GOOG	Alphabet Inc Class C

When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:

How To Invest In Thermo

Details

Is Thermo Stock a good investment?

Details

What is Thermo Fisher's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Thermo Stock analysis

When running Thermo Fisher's price analysis, check to measure Thermo Fisher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Thermo Fisher is operating at the current time. Most of Thermo Fisher's value examination focuses on studying past and present price action to predict the probability of Thermo Fisher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Thermo Fisher's price. Additionally, you may evaluate how the addition of Thermo Fisher to your portfolios can decrease your overall portfolio volatility.

	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	AI Investment Finder Use AI to screen and filter profitable investment opportunities
	Insider Screener Find insiders across different sectors to evaluate their impact on performance

Is Thermo Fisher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.054

Dividend Share

1.4

Earnings Share

15.47

Revenue Per Share

111.028

Quarterly Revenue Growth

(0.05)

The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Thermo Profit Margin vs Accounts Payable Analysis

Net Profit Margin vs Accounts Payable

Profit Margin vs Accounts Payable Correlation Analysis

Correlation Coefficient

Net Profit Margin

Accounts Payable

Thermo Fisher fundamental ratios Correlations

Thermo Fisher Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thermo Fisher fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Thermo Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Total Liab	+ 1.0	Short Long Term Debt Total
Net Receivables	+ 1.0	Property Plant And Equipment Net
Accounts Payable	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 1.0	Non Current Assets Total

Property Plant And Equipment Gross	- 0.62	Other Stockholder Equity
Current Deferred Revenue	- 0.59	Other Stockholder Equity
Other Stockholder Equity	- 0.53	Retained Earnings
Other Stockholder Equity	- 0.51	Property Plant And Equipment Net
Total Current Assets	- 0.49	Other Stockholder Equity
Other Stockholder Equity	- 0.49	Cash And Short Term Investments